Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06200012 · ClinicalTrials.gov registry record · NA
Multi-Level Stigma Intervention for Mental Health Services
A NA study, sponsored by Wayne State University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT06200012: Completed NA study, sponsored by Wayne State University.
NCT06200012 is a NA study that has completed, run by Wayne State University. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06200012, a NA study, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This cluster randomized trial develops and pilot tests a multi-level substance use stigma intervention that leverages organizational policy and professional education to address structural and professional drivers of stigma in outpatient mental health (MH) services. The investigators will generate preliminary data to determine whether adding an organizational policy to a professional stigma training may reduce measures of provider-based stigma towards substance use and improve care quality and patient outcomes to a greater degree than simply conducting training alone. The investigators hypothesize that providers at a MH site implementing an organizational policy change in addition to providing professional training will demonstrate greater improvement to health services for people who use drugs compared to a site where providers receive training alone.
Primary Outcome
Identified ICD-10s or notes among participating providers in electronic health records (EHR)
Interventions
- BEHAVIORAL Multi-level stigma reduction intervention: educational training plus controlled substance agreement policy change
- BEHAVIORAL Single-level stigma reduction intervention: educational training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-11-06 |
| Est. Completion | 2025-02-08 |
| Phase | NA |
What the finished NCT06200012 record still lists
NCT06200012 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Multi-level stigma reduction intervention: educational training plus controlled substance agreement policy change is the first listed.
NCT06200012 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06200012 about?
NCT06200012 is a clinical study titled "Multi-Level Stigma Intervention for Mental Health Services". This cluster randomized trial develops and pilot tests a multi-level substance use stigma intervention that leverages organizational policy and professional education to address structural and professional drivers of stigma in outpatient mental health (MH) services. The investigators will generate p...
What is the current status of trial NCT06200012?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2023-11-06. Estimated completion is 2025-02-08.
What interventions are being tested in trial NCT06200012?
The interventions under investigation include: Multi-level stigma reduction intervention: educational training plus controlled substance agreement policy change (BEHAVIORAL), Single-level stigma reduction intervention: educational training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06200012?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06200012's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI